BRIEF-AIT Therapeutics Announces Further Data From Its NO-NTM Abscessus Phase 2 Clinical Trial

Jan 22 (Reuters) – Ait Therapeutics Inc:

* AIT THERAPEUTICS ANNOUNCES FURTHER DATA FROM ITS NO-NTM ABSCESSUS PHASE 2 CLINICAL TRIAL IN NONTUBERCULOUS MYCOBACTERIA (NTM) PATIENTS Source text for Eikon: Further company coverage:



Learn More about trading signals

What do you think?

0 points
Upvote Downvote

Total votes: 0

Upvotes: 0

Upvotes percentage: 0.000000%

Downvotes: 0

Downvotes percentage: 0.000000%

BRIEF-VICI Properties Inc Sees IPO Of Up To 50 Million Shares Of Common Stock

Abercrombie lifts holiday-quarter forecasts; shares surge